Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

Share Price is delayed by 15 minutes
Get Live Data
5.75    -0.10 (-1.71%)
Bid:
5.70
Ask:
5.80
Spread: 0.10 (1.754%)
Market Cap: £61.50m
STX Live PriceLast checked at - London Stock Exchange

Intraday Shield Thera Share Chart

Shield Thera News

Shield Therapeutics inks licencing agreement for iron deficiency drug
22 Apr 2025

Shield Therapeutics inks licencing agreement for iron deficiency drug

(Alliance News) - Shield Therapeutics PLC on Tuesday reported an exclusive deal with a Japanese distributor, as it looks keep expanding Accrufer's glo...

Shield Therapeutics inks exclusive licence agreement in Japan
22 Apr 2025

Shield Therapeutics inks exclusive licence agreement in Japan

(Sharecast News) - Pharmacitucal firm Shield Therapeutics said on Tuesday that it had inked an exclusive licence agreement for its ACCRUFeR iron defic...

TRADING UPDATES: BP Marsh's new buyback; Iofina lowers production view
17 Apr 2025

TRADING UPDATES: BP Marsh's new buyback; Iofina lowers production view

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Shield Therapeutics shares surge as revenue up on prescription growth
5 Feb 2025

Shield Therapeutics shares surge as revenue up on prescription growth

(Alliance News) - Shield Therapeutics PLC shares jumped on Wednesday as its revenue soared in 2024 and it said it expects to be cash flow positive by ...

EXECUTIVE CHANGES: Smithson changes chairs; British Land taps new COO
28 Jan 2025

EXECUTIVE CHANGES: Smithson changes chairs; British Land taps new COO

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced in the past week and not separately repo...

Shield Therapeutics appoints Anders Lundstrom as permanent CEO
27 Jan 2025

Shield Therapeutics appoints Anders Lundstrom as permanent CEO

(Sharecast News) - Shield Therapeutics announced the appointment of Anders Lundstrom as its permanent chief executive officer on Monday, effective 1 F...

Shield Therapeutics to raise USD10.0 million via AOP subscription
6 Dec 2024

Shield Therapeutics to raise USD10.0 million via AOP subscription

(Alliance News) - Shield Therapeutics PLC on Friday said it intends to raise USD10.0 million via a share subscription, and launched a retail offer to ...